kabutan

Renascience Inc.(4889) Summary

4889
TSE Growth
Renascience Inc.
1,453
JPY
+15
(+1.04%)
Jan 29, 3:05 pm JST
9.49
USD
Jan 29, 1:05 am EST
Result
PTS
outside of trading hours
1,442.1
Jan 29, 3:00 pm JST
Summary Chart Historical News Financial Result
PER
PBR
12.3
Yield
ー%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,420 JPY 9.27 USD
Previous Close Jan 28
1,438 JPY 9.42 USD
High Jan 29, 12:38 pm
1,458 JPY 9.52 USD
Low Jan 29, 9:17 am
1,416 JPY 9.25 USD
Volume
71,000
Trading Value
0.10B JPY 0.67M USD
VWAP
1437.09 JPY 9.39 USD
Minimum Trading Value
145,300 JPY 949 USD
Market Cap
0.02T JPY 0.13B USD
Number of Trades
375
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
4,455
1-Year High May 21, 2025
38,929
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 100 1,504,100 15041.00
Jan 16, 2026 100 1,465,500 14655.00
Jan 9, 2026 100 1,423,000 14230.00
Dec 26, 2025 1,700 1,451,200 853.65
Dec 19, 2025 0 1,518,500
Company Profile
Renascience Inc. is a drug discovery venture originating from Tohoku University. The company focuses on developing therapeutic drugs using small molecule compounds and leverages AI for medical solutions.
Sector
Pharmaceuticals
Renascience Inc., a drug discovery venture born out of Tohoku University, is advancing the development of therapeutic drugs using small molecule compounds, with a focus on PAI-1 inhibitors. The company conducts clinical development in areas related to aging and lifestyle-associated diseases, including cancer, respiratory diseases, and mental disorders, and has a strong track record in physician-led clinical trials. Renascience Inc. is also committed to developing AI-powered medical devices, with pipelines in pulmonary function test diagnostics, maintenance hemodialysis support, and diabetes treatment assistance. The company emphasizes collaborative research with universities and medical institutions, having established an open innovation laboratory. With an integrated research and development system spanning from basic research to clinical development, Renascience Inc. aims to create medical innovations.